Item from Punto Farma
Vedilep Multidose Carvedilol 25 mg - 28 Tri-scored Tablets
SKU #03444743≈ $15
Updated: 07.11.2026 09:37
The price may differ from the price on Punto Farma's website.
Important: a product from a pharmacy
We recommend taking medicines only on a doctor's prescription. TodosPy is not a seller of medicines: we only collect products and medicines from different sources and show them to you in a convenient way on one site. The final purchase, payment and delivery take place only on the pharmacy's own website or in the pharmacy itself, depending on its terms of sale and delivery.
Description
Acción Terapéutica: Antianginoso - Antihipertensivo. Indicaciones: Hipertensión arterial esencial. Angina de pecho estable. Insuficiencia cardíaca congestiva. Posología: A criterio médico. Dosis de inicio: 3,125 mg., incrementando la dosis de manera progresiva. Las dosis deben titularse en intervalos cada dos semanas. Contraindicaciones: El medicamento se encuentra contraindicado en pacientes con bradicardia severa (menos de 45-50 latidos/min), shock cardiogénico, bloqueo de rama de segundo y tercer grado, enfermedad del nódulo sinusal (incluyendo bloqueo sino-auricular), insuficiencia cardiaca descompensada (clase IV NYHA) que requiera tratamiento inotrópico intravenoso, hipotensión severa (presión arterial sistólica <85 mm Hg), antecedentes de enfermedad obstructiva de las vías aéreas, asma, insuficiencia hepática e hipersensibilidad conocida a carvedilol o a los componentes del producto.
Product summary
Vedilep Multidose Carvedilol 25 mg - 28 Tri-scored Tablets is a product in the “Medicines” category from the shop Punto Farma. Price: 90.000 Gs (≈ $15). Key characteristics: Brand: LEPETIT.
Price compared with the category
The “Medicines” category has 17419 products from 5 shops: prices from 360 to 6.639.826 Gs, median price 70.579 Gs. This product costs more than 50% of the products in the category.
Specifications
You complete the purchase on Punto Farma's website.
Customer reviews
Nobody has reviewed this product yet.
